Renal artery interventions could damage kidneys
A Wake Forest University study has confirmed that plaque fragments released during renal artery revascularization could impair kidney function. Findings suggest physicians may need to rethink how to perform these procedures safely.
A Wake Forest University study has confirmed that plaque fragments released during renal artery revascularization could impair kidney function. Findings suggest physicians may need to rethink how to perform these procedures safely.
Dr. Matthew Edwards and colleagues assessed 28 patients who underwent renal artery angioplasty and stenting between July 2005 and December 2006. The investigators used a protective device to keep plaque fragments from passing through the vessel. Blood samples taken from the occluded area carried embolic particles large enough to disrupt renal function (J Vasc Surg 2007;46[1]:55-61).
Findings showed a statistically significant association between stent size and the release of potentially hazardous particles. Aspirin, on the other hand, helped reduce debris counts. Researchers could not establish the true role protective devices play in this setting.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
